Risk of venous thromboembolism from use of oral contraceptives containing different progestogens and oestrogen doses: Danish cohort study, 2001-9

Lidegaard, O., Nielsen, L. H., Skovlund, C. W., Skjeldestad, F. E., Lokkegaard, E.·2011·BMJ

DOI 10.1136/bmj.d6423

Cited by (607)

Items 101–200 of 607

Heavy menstrual bleeding: work-up and management
Allison James · 2016 · Hematology
Progestin-only contraception and venous thromboembolism
María Á. Blanco-Molina, Miquel Lozano, A. Cano, Ignacio Cristóbal García, LM Pallardó, Iñaki Lete · 2012 · Thrombosis Research
Hormonal Contraception and Risk of Thromboembolism in Women With Diabetes
Sarah H. O’Brien, Terah L. Koch, Sara K. Vesely, Eleanor Bimla Schwarz · 2016 · Diabetes Care
How I treat heavy menstrual bleeding associated with anticoagulants
Kochawan Boonyawat, Sarah H. O’Brien, Shannon M. Bates · 2017 · Blood
Thrombosis in women: what are the knowledge gaps in 2013?
Saskia Middeldorp · 2013 · Journal of Thrombosis and Haemostasis
Adolescents with Special Needs: Clinical Challenges in Reproductive Health Care
Elisabeth H. Quint · 2015 · Journal of Pediatric and Adolescent Gynecology
Long‐term use of dienogest for the treatment of primary and secondary dysmenorrhea
Yutaka Osuga, Kôichi Hayashi, Shingo Kanda · 2020 · Journal of obstetrics and gynaecology research
Mechanisms of hormonal therapy related thrombosis
Per Morten Sandset · 2013 · Thrombosis Research
Cardiovascular toxicity of abacavir
Ángeles Álvarez, Samuel Orden, Isabel Andújar, Víctor Collado‐Díaz, Sara Núñez-Delgado, Marı́a José Galindo, Vicente Estrada, Nadezda Apostolova, Juan Vicente Esplugues · 2017 · AIDS
Ventilatory Response to Hypoxia and Tolerance to High Altitude in Women: Influence of Menstrual Cycle, Oral Contraception, and Menopause
Jean‐Paul Richalet, François Lhuissier, Dominique Jean · 2019 · High Altitude Medicine & Biology
The prolactin receptor as a therapeutic target in human diseases: browsing new potential indications
Vincent Goffin, Philippe A. Touraine · 2015 · Expert Opinion on Therapeutic Targets
Epidemiology, risk factors and sequelae of venous thromboembolism
Peng Foo Wong, Trevor P Baglin · 2012 · Phlebology The Journal of Venous Disease
Analysis of Risk Factors of Stroke and Venous Thromboembolism in Females With Oral Contraceptives Use
Petr Ďulíček, E.Y. Ivanova, Milan Košťál, Petr Sadílek, Martin Beránek, Павел Зак, Jana Hirmerová · 2017 · Clinical and Applied Thrombosis/Hemostasis
Systematic Review of Hormonal Contraception and Risk of Venous Thrombosis
Lynn Keenan, Tyson Kerr, Marguerite Duane, Karl Van Gundy · 2018 · The Linacre Quarterly
Polycystic ovary syndrome: A review for dermatologists
Elizabeth A. Buzney, Johanna Sheu, Catherine D. Buzney, Rachel V. Reynolds · 2014 · Journal of the American Academy of Dermatology
Risk factors for venous thromboembolism in women under combined oral contraceptive
Agathe Henneuse, Manal Ibrahim, Dominique Brunet, Marie-Christine Barthet, Marie-Françoise Aillaud, Geoffroy Venton, Marie‐Christine Alessi, David‐Alexandre Trégouët, Pierre Suchon, Fadi Al Frouh et al. · 2015 · Thrombosis and Haemostasis
Sex matters: Practice 5P's when treating young women with venous thromboembolism
Ingrid M. Bistervels, Luuk J.J. Scheres, Eva N. Hamulyák, Saskia Middeldorp · 2019 · Journal of Thrombosis and Haemostasis
Proposal for targeted, neo-evolutionary-oriented secondary prevention of early-onset endometriosis and adenomyosis. Part II: medical interventions
Paolo Vercellini, Veronica Bandini, Paola Viganò, Deborah Ambruoso, Giulia Emily Cetera, Edgardo Somigliana · 2023 · Human Reproduction
European Society of Contraception Statement on Contraception in Obese Women
Gabriele S. Merki‐Feld, Sven Olaf Skouby, D. Serfaty, Medard M. Lech, Johannes Bitzer, Pier Giorgio Crosignani, Angelo Cagnacci, Regine L. Sitruk-Ware · 2014 · The European Journal of Contraception & Reproductive Health Care
Oral tranexamic acid and thrombosis risk in women
Amani Meaidi, Lina Steinrud Mørch, Christian Tobias Torp-Pedersen, Oejvind Lidegaard · 2021 · EClinicalMedicine
Obesity and Contraceptive Use: Impact on Cardiovascular Risk
Giuseppe M.C. Rosano, Maria Angeles Rodriguez‐Martinez, Ilaria Spoletini, Pedro‐Antonio Regidor · 2022 · ESC Heart Failure
Tolerability considerations for gonadotropin-releasing hormone analogues for endometriosis
Luigi Della Corte, Fabio Barra, Antonio Mercorio, Giulio Evangelisti, Agnese Maria Chiara Rapisarda, Simone Ferrero, Giuseppe Bifulco, Pierluigi Giampaolino · 2020 · Expert Opinion on Drug Metabolism & Toxicology
Off-label drug use in the treatment of polycystic ovary syndrome
Wendy Vitek, Snigdha Alur-Gupta, Kathleen M. Hoeger · 2015 · Fertility and Sterility
Polycystic ovary syndrome: chemical pharmacotherapy
Morena Luigia Rocca, Roberta Venturella, Rita Mocciaro, Annalisa Di Cello, Angela Sacchinelli, Valentina M. Russo, Simona Trapasso, Fulvio Zullo, Michele Morelli · 2015 · Expert Opinion on Pharmacotherapy
Gestodene: A review of its pharmacology, potency and tolerability in combined contraceptive preparations
Frank Z. Stanczyk, David F. Archer · 2013 · Contraception
Drospirenone as estrogen-free pill and hemostasis: coagulatory study results comparing a novel 4 mg formulation in a 24 + 4 cycle with desogestrel 75 μg per day
Pedro‐Antonio Regidor, Enrico Colli, Adolf Eduard Schindler · 2016 · Gynecological Endocrinology
Contraceptive care for Canadian youth
Giuseppina Di Meglio, Colleen Crowther, Joanne Simms · 2018 · Paediatrics & Child Health
A Systematic Review and Meta-analysis of the Adverse Effects of Levonorgestrel Emergency Oral Contraceptive
Nattawut Leelakanok, Janthima Methaneethorn · 2020 · Clinical Drug Investigation
Pulmonary embolism: Age specific temporal trends in incidence and mortality in Denmark 1999–2018
Emilie Sonne-Holm, Jesper Kjærgaard, Lia Evi Bang, Emil Loldrup Fosbøl, Jørn Carlsen, Matilde Winther‐Jensen · 2021 · Thrombosis Research
Tolerability and safety of the estetrol/drospirenone combined oral contraceptive: Pooled analysis of two multicenter, open-label phase 3 trials
Melissa J. Chen, Jeffrey T. Jensen, Andrew M. Kaunitz, Sharon L. Achilles, János Zatik, Steven Weyers, Terhi Piltonen, Л. В. Сутурина, Аполихина Инна Анатольевна, Céline Bouchard et al. · 2022 · Contraception
Risk of recurrent venous thromboembolism on progestin-only contraception: a cohort study
Emmanuelle Le Moigne, Cécile Tromeur, Aurélien Delluc, Maëlenn Gouillou, Zarrin Alavi, Karine Lacut, Dominique Mottier, Grégoire Le Gal · 2015 · Haematologica
Oral contraceptive use among women aged 15 to 49: Results from the Canadian Health Measures Survey.
Michelle Rotermann, Sheila Dunn, Amanda Black · 2015 · PubMed
Risk of Venous Thromboembolism in Transgender People Undergoing Hormone Feminizing Therapy: A Prevalence Meta-Analysis and Meta-Regression Study
Maria Totaro, Sara Palazzi, Chiara Castellini, Antonio Parisi, Federica D’Amato, Daniele Tienforti, Marco Giorgio Baroni, Sandro Francavilla, Arcangelo Barbonetti · 2021 · Frontiers in Endocrinology
Stroke and myocardial infarction with contemporary hormonal contraception: real-world, nationwide, prospective cohort study
Harman Gailan Hassan Yonis, Ellen Løkkegaard, Kristian Hay Kragholm, Christopher Bull Granger, Amalie Lykkemark Møller, Lina Steinrud Mørch, Christian Tobias Torp-Pedersen, Amani Meaidi · 2025 · BMJ
Combined oral contraceptives, venous thromboembolism, and the problem of interpreting large but incomplete datasets
Jürgen Dinger, Samuel Shapiro · 2011 · Journal of Family Planning and Reproductive Health Care
Defining venous thromboembolism and measuring its incidence using Swedish health registries: a nationwide pregnancy cohort study
Alyshah Abdul Sultan, Joe West, Olof Stephansson, Matthew J. Grainge, Laila Jal Tata, Kate M. Fleming, David James Humes, Jonas Filip Ludvigsson · 2015 · BMJ Open
Oral contraceptives and hormone replacement therapy: How strong a risk factor for venous thromboembolism?
Leslie Skeith, Grégoire Le Gal, Marc Alan Rodger · 2021 · Thrombosis Research
Effects of hormone therapy on blood pressure
Zeinab Ali Issa, Ellen W. Seely, Maya Rahme, Ghada El‐Hajj Fuleihan · 2014 · Menopause The Journal of The North American Menopause Society
Venous thromboembolism with use of hormonal contraception and non-steroidal anti-inflammatory drugs: nationwide cohort study
Amani Meaidi, Annamaria Mascolo, Maurizio Sessa, Anne Pernille Toft‐Petersen, Regitze Gyldenholm Skals, Thomas Alexander Gerds, Charlotte Wessel Skovlund, Lina Steinrud Mørch, Francesco Rossi, Annalisa Capuano et al. · 2023 · BMJ
Estrogen, progestin, and beyond: thrombotic risk and contraceptive choices
Leslie Skeith, Shannon M. Bates · 2024 · Hematology
Venous thromboembolism and women's health
Victoria Speed, Lara N. Roberts, Jignesh Prakash Patel, Roopen Arya · 2018 · British Journal of Haematology
Hypercoagulability in adolescent girls on oral contraceptives‐global coagulation profile and estrogen receptor polymorphisms
Ayesha N Zia, Michael U. Callaghan, Joseph H. Callaghan, Anju Sawni, Heather Bartlett, Alcesa Backos, Sharon P. Marshall, Meera Chitlur, Madhvi Rajpurkar · 2015 · American Journal of Hematology
Risks of thromboembolism associated with hormonal contraceptives related to body mass index and aging in Japanese women
Kazuko Sugiura, Takao Kobayashi, Toshiyuki Ojima · 2015 · Thrombosis Research
Is There Really Increased Cardiovascular Morbidity in Women with Polycystic Ovary Syndrome?
Enrico Carmina, Roger A. Lobo · 2018 · Journal of Women s Health
Obesity and hormonal contraception: an overview and a clinician’s practical guide
Sarah Cipriani, Tommaso Todisco, Irene Scavello, Vincenza Di Stasi, Elisa Maseroli, Linda Vignozzi · 2019 · Eating and Weight Disorders - Studies on Anorexia Bulimia and Obesity
Risk factors and clinical features of acute pulmonary embolism in children from the community
Charlie Yue Wang, Vera Ignjatović, Peter St. John Francis, Timothy M. Cain, Franz E Babl, Remi R. Kowalski, Andrew Donald Cochrane, Paul Monagle · 2015 · Thrombosis Research
Association between oral contraceptives and risk of hemorrhagic stroke: a meta-analysis of observational studies
Xu, Zhenlin, Yue, Yuanping, Bai, Jianling, Shen, Chong, Yang, Jingjing, Huang, Xiaoping, Zhao, Yang, Li, Ying · 2018 · Archives of Gynecology and Obstetrics
Concepts of Contraception for Adolescent and Young Adult Women with Chronic Illness and Disability
Donald E. Greydanus, Helen D. Pratt, Dilip R. Patel · 2012 · Disease-a-Month
Oral contraceptive use and impact of cumulative intake of estrogen and progestin on risk of ovarian cancer
Mette Tuxen Faber, Allan Jensen, Kirsten Frederiksen, Eva Glud, Estrid Vilma Solyom Høgdall, Claus Kim Høgdall, Jan Blaakær, Susanne K. Kjær · 2013 · Cancer Causes & Control
An update on PCOS in adolescents
Shannon Fitzgerald, Amy Desrochers DiVasta, Holly C. Gooding · 2018 · Current Opinion in Pediatrics
The Risk of Venous Thromboembolism with Different Generation of Oral Contraceptives; a Systematic Review and Meta-Analysis.
Alireza Baratloo, Saeed Safari, Alaleh Rouhipour, Behrooz Hashemi, Farhad Rahmati, Maryam Motamedi, Mohammadmehdi Forouzanfar, Pauline Haroutunian · 2014 · Archives of Academic Emergency Medicine
Risk of venous thrombosis in users of hormonal contraceptives in German gynaecological practices: a patient database analysis
M. Ziller, Volker Ziller, Gabriele Haas, Juliana Rex, Karel Kostev · 2013 · Archives of Gynecology and Obstetrics
Canadian Contraception Consensus (Part 3 of 4): Chapter 8 – Progestin-Only Contraception
Amanda Black, Édith Guilbert, Dustin Costescu, Sheila Dunn, William A. Fisher, Sari Leanne Kives, Melissa Mirosh, Wendy V. Norman, Helen C. Pymar, Robert L. Reid et al. · 2016 · Journal of Obstetrics and Gynaecology Canada
Contraception and the dermatologist
Kelly H. Tyler, Matthew Zirwas · 2013 · Journal of the American Academy of Dermatology
Fertility, Contraception, and Novel Reproductive Technologies in Chronic Kidney Disease
Sofia Bano Ahmed, Wendy Vitek, Jean L. Holley · 2017 · Seminars in Nephrology
Contraception, Venous Thromboembolism, and Inflammatory Bowel Disease: What Clinicians (and Patients) Should Know
Jimmy K. Limdi, Jennifer Farraye, Rachel Cannon, Elisabeth J. Woodhams, Francis A. Farraye · 2019 · Inflammatory Bowel Diseases
Oral contraception in Denmark 1998–2010
Nadia Wilson, Maja Laursen, Øjvind Lidegaard · 2012 · Acta Obstetricia Et Gynecologica Scandinavica
Impact of the sharp changes in the use of contraception in 2013 on the risk of pulmonary embolism in France
Aurore Tricotel, Cédric Collin, Mahmoud Zureik · 2015 · Journal of Thrombosis and Haemostasis
Statement on combined hormonal contraceptives containing third- or fourth-generation progestogens or cyproterone acetate, and the associated risk of thromboembolism
Johannes Bitzer, Jean‐Jacques Amy, R.J.C.M. Beerthuizen, Martin Birkhäuser, Teresa Bombas, Mitchell David Creinin, Philip D. Darney, Lisa Ferreira Vicente, Kristina Gemzell‐Danielsson, Bruno Imthurn et al. · 2013 · The European Journal of Contraception & Reproductive Health Care
Pooled analysis of two phase 3 trials evaluating the effects of a novel combined oral contraceptive containing estetrol/drospirenone on bleeding patterns in healthy women
Andrew M. Kaunitz, Sharon L. Achilles, János Zatik, Steven Weyers, Terhi Piltonen, Л. В. Сутурина, Аполихина Инна Анатольевна, Céline Bouchard, Melissa J. Chen, Jeffrey T. Jensen et al. · 2022 · Contraception
Diminished Ovarian Reserve in Endometriosis: Insights from In Vitro, In Vivo, and Human Studies—A Systematic Review
Zhouyurong Tan, Xue Gong, Chi Chiu Wang, Tao Zhang, Jin Long Huang · 2023 · International Journal of Molecular Sciences
The effect of hormonal contraceptive therapy on clinical laboratory parameters: a literature review
Ömer Özcan, Wendy P. J. den Elzen, Jacquelien J Hillebrand, Martin den Heijer, L.L. van Loendersloot, Johan Fischer, Henrike M. Hamer, Róbert de Jonge, Annemieke C. Heijboer · 2023 · Clinical Chemistry and Laboratory Medicine (CCLM)
Combined Hormonal Contraceptives and Venous Thromboembolism
Elizabeth G. Raymond, Anne E. Burke, Eve L. Espey · 2012 · Obstetrics and Gynecology
Computer-assisted provision of hormonal contraception in acute care settings
Eleanor Bimla Schwarz, Elizabeth Burch, Sara M. Parisi, Kathleen Tebb, Daniel Grossman, Ateev Mehrotra, Ralph Gonzales · 2012 · Contraception
Clotting factor changes during the first cycle of oral contraceptive use
Carolyn L. Westhoff, Andrew B. Eisenberger, Rosalind Tang, Serge Cremers, Lisa Grossman Liu, Malcolm C. Pike · 2015 · Contraception
Endothelial mineralocorticoid receptor activation enhances endothelial protein C receptor and decreases vascular thrombosis in mice
Jérémy Lagrange, Zhenlin Li, Céline Fassot, Mustapha Bourhim, Huguette Louis, Aurélie Nguyen Dinh Cat, Ara Parlakian, Denis G. Wahl, Patrick J. Lacolley, Frédéric Jaisser et al. · 2014 · The FASEB Journal
The effect of different hormonal contraceptives on plasma levels of free protein S and free TFPI
Frans M. Helmerhorst, Kathrin Fleischer, Anders Erik Astrup Dahm, Frits Richard Rosendaal, Jan Rosing, Pieter H. Reitsma, Per Morten Sandset, Huib A.A.M. van Vliet, Marjolein Raps · 2013 · Thrombosis and Haemostasis
Health benefits of combined oral contraceptives – a narrative review
Herjan J.T. Coelingh Bennink, Femke A. M. van Gennip, Mireille Gerrits, Jan F M Egberts, Kristina Gemzell‐Danielsson, Helena Kopp Kallner · 2024 · The European Journal of Contraception & Reproductive Health Care
Unique Vascular Benefits of Estetrol, a Native Fetal Estrogen with Specific Actions in Tissues (NEST)
Jean‐Michel Foidart, U Gaspard, Christel Péqueux, Maud Jost, Valérie Gordenne, Ekaterine Tskitishvili, A Gallez, Marie‐Cécile Valera, Pierre Gourdy, Coralie Fontaine et al. · 2019 · ISGE series
The contraception needs of the perimenopausal woman
Sarah Margaret Hardman, Ailsa E. Gebbie · 2014 · Best Practice & Research Clinical Obstetrics & Gynaecology
Contraception in autoimmune diseases
Giuseppe Benagiano, Marisa Benagiano, Paola Bianchi, Mario Milco D’Elios, Ivo A Brosens · 2019 · Best Practice & Research Clinical Obstetrics & Gynaecology
Metabolic and laboratory effects of a progestin-only pill containing drospirenone 4 mg in comparison to desogestrel 75 µg: a double-blind, double-dummy, prospective, randomised study
Santiago Palacios, Enrico Colli, Pedro‐Antonio Regidor · 2021 · The European Journal of Contraception & Reproductive Health Care
Effects of combined oral contraceptives containing levonorgestrel or chlormadinone on the endothelium
Sílvio Antônio Franceschini, Carolina Sales Vieira, Wellington P. Martins, Janaína Boldrini França, Rui Alberto Ferriani · 2012 · Contraception
Safer prescribing of therapeutic norethisterone for women at risk of venous thromboembolism
Diana Mansour · 2012 · Journal of Family Planning and Reproductive Health Care
Contraceptive and hormonal treatment options for women with history of venous thromboembolism
Manon C. Stam‐Slob, Cornelis Bavo Lambalk, Marcel A. van de Ree · 2015 · BMJ
Effect of Progesterone and Synthetic Progestins on Whole Blood Clot Formation and Erythrocyte Structure
Albe C. Swanepoel, Odette Emmerson, Etheresia Pretorius · 2017 · Microscopy and Microanalysis
Optimal management of hormonal contraceptives after an episode of venous thromboembolism
Frederikus Albertus Klok, Stefano Barco · 2019 · Thrombosis Research
Effects of the etonogestrel-releasing contraceptive implant inserted immediately postpartum on maternal hemostasis: A randomized controlled trial
Milena Bastos Brito, Rui Alberto Ferriani, Joost C.M. Meijers, Andrea Aparecida Garcia, Silvana Maria Quintana, Marcos Felipe Silva de Sá, Carolina Sales Vieira · 2012 · Thrombosis Research
Thromboembolic Events in Women Exposed to Hormonal Contraception or Cyproterone Acetate in 2012: A Cross-Sectional Observational Study in 30 French Public Hospitals
Mathilde Gourbil, Aurélie Grandvuillemin, Marie‐Noëlle Beyens, Nathalie Massy, Valérie Gras, Andrea Beatriz Damico, Ghada Miremont‐Salamé, Nadine Petitpain · 2014 · Drug Safety
Prevention and treatment of venous thromboembolism during HRT: current perspectives
Hannelore Rott · 2014 · International Journal of General Medicine
Detecting adverse drug reactions following long-term exposure in longitudinal observational data: The exposure-adjusted self-controlled case series
Martijn J. Schuemie, Gianluca Trifirò, Preciosa M. Coloma, Patrick B. Ryan, David Madigan · 2014 · Statistical Methods in Medical Research
Drug safety evaluation of desogestrel
Carolina Scala, Umberto Leone Roberti Maggiore, Valentino Remorgida, Pier Luigi Venturini, Simone Ferrero · 2013 · Expert Opinion on Drug Safety
Oral contraceptives and cardiovascular risk in women with polycystic ovary syndrome.
Enrico Carmina · 2013 · PubMed
Estimate of Venous Thromboembolism and Related-Deaths Attributable to the Use of Combined Oral Contraceptives in France
Aurore Tricotel, Fanny RAGUIDEAU, Cédric Collin, Mahmoud Zureik · 2014 · PLoS ONE
Pregnancy is more dangerous than the pill: A critical analysis of professional responses to the Yaz/Yasmin controversy
Alina Geampana · 2016 · Social Science & Medicine
Drospirenone and non-fatal venous thromboembolism: Is there a risk difference by dosage of ethinyl-estradiol?
Bird, S.T., Delaney, J.A.C., Etminan, M., Brophy, J.M., Hartzema, A.G. · 2013 · Journal of Thrombosis and Haemostasis
Impact of Estetrol Combined with Drospirenone on Blood Coagulation and Fibrinolysis in Patients with Endometriosis: A Multicenter, Randomized, Open-Label, Active-Controlled, Parallel-Group Study
Takao Kobayashi, Masashi Hirayama, Masayoshi Nogami, Kanna Meguro, Masato Iiduka, Jean‐Michel Foidart, Jonathan Douxfils, Tasuku Harada · 2024 · Clinical and Applied Thrombosis/Hemostasis
Statement on combined hormonal contraceptives containing third- or fourth-generation progestogens or cyproterone acetate, and the associated risk of thromboembolism
Johannes Bitzer, Jean‐Jacques Amy, R.J.C.M. Beerthuizen, Martin Birkhäuser, Teresa Bombas, Mitchell David Creinin, Philip D. Darney, Lisa Ferreira Vicente, Kristina Gemzell‐Danielsson, Bruno Imthurn et al. · 2013 · Journal of Family Planning and Reproductive Health Care
FSRH Guideline (January 2019, amended October 2023) Combined Hormonal Contraception
2019 · BMJ Sexual & Reproductive Health
Pharmacological and metabolic effects of drospirenone as a progestin-only pill compared to combined formulations with estrogen
Pedro‐Antonio Regidor, Anna Sophie Mueller, Manuela Mayr · 2023 · Women s Health
Tamoxifen induces resistance to activated protein C
Heiko Rühl, Lars Schröder, Jens Müller, Rolf Fimmers, Shorena Sukhitashvili, Julia Welz, Walther Christian Kuhn, Johannes Oldenburg, Christian Rudlowski, Bernd Pötzsch · 2014 · Thrombosis Research
Venous Thromboembolism Due to Oral Contraceptive Intake and Spending Nights in a Vehicle -A Case from the 2016 Kumamoto Earthquakes-
Daisuke Sueta, Rika Akahoshi, Yoshinori Okamura, Sunao Kojima, Tomokazu Ikemoto, Eiichiro Yamamoto, Yasuhiro Izumiya, Kenichi Tsujita, Koichi Kaikita, Hidetaka Katabuchi et al. · 2017 · Internal Medicine
Endogenous thrombin potential changes during the first cycle of oral contraceptive use
Carolyn L. Westhoff, Malcolm C. Pike, Serge Cremers, Andrew B. Eisenberger, Stella Thomassen, Jan Rosing · 2017 · Contraception
Combined oral contraceptives: venous thrombosis
Marcos de Bastos, Bernardine H. Stegeman, Frits Richard Rosendaal, Astrid van Hylckama Vlieg, Frans M. Helmerhorst, Theo Stijnen, Olaf M. Dekkers · 2013 · Cochrane Database of Systematic Reviews
Combined oral contraceptives may activate the contact system in healthy women
Jesper Strandberg, Inger Lise Gade, Yaseelan Palarasah, Jørgen Gram, Søren Risom Kristensen, Johannes Jakobsen Sidelmann · 2023 · Research and Practice in Thrombosis and Haemostasis
Cardiovascular Data Quality in the Danish National Patient Registry (1977–2024): A Systematic Review
Katrine Hjuler Lund, Cecilia Hvitfeldt Fuglsang, Sigrún Alba Jóhannesdóttir Schmidt, Morten Schmidt · 2024 · Clinical Epidemiology
Progestin-only contraception and thrombosis: An updated systematic review
Naomi K. Tepper, Antoinette T. Nguyen, Maura K. Whiteman, Kathryn M. Curtis · 2025 · Contraception
Multicenter, open-label trial to assess the safety and tolerability of drospirenone 4.0 mg over 6 cycles in female adolescents, with a 7-cycle extension phase
Dan L Apter, Enrico Colli, Kristina Gemzell‐Danielsson, Klaus Peters · 2020 · Contraception
Contraception During Perimenopause: Practical Guidance
Giovanni Grandi, Pierluigi Di Vinci, Alice Sgandurra, Lia Feliciello, Francesca Monari, Fabio Facchinetti · 2022 · International Journal of Women s Health
Use of oral contraceptives for management of acne vulgaris and hirsutism in women of reproductive and late reproductive age
Radosław Słopień, Ewa Milewska, Piotr Rynio, Błażej Męczekalski · 2018 · Menopause Review/Przegląd Menopauzalny